Stock comparison
Eli Lilly
Teleflex
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
TFX
Teleflex
Market cap
$5.74B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | TFX | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 24F | LLY |
| Benjamin Graham | 76B | 26F | LLY |
| Philip Fisher | 75B | 23F | LLY |
| Peter Lynch | 64C | 1F | LLY |
| Joel Greenblatt | 68B | 27F | LLY |
| Charlie Munger | 75B | 18F | LLY |
| Terry Smith | 66B | 15F | LLY |
Side-by-side metrics
| Metric | LLY | TFX |
|---|---|---|
| Market cap | $946.37B | $5.74B |
| P/E (TTM) | 35.6x | - |
| EV/EBIT | 33.2x | 21.9x |
| ROIC (TTM) | 32.06% | 2.73% |
| Gross margin | 83.51% | 53.27% |
| Net margin | 34.98% | -35.89% |
| Revenue CAGR 5y | 23.17% | -8.23% |
| EPS CAGR 5y | 40.81% | - |
| Debt / Equity | 1.4x | 0.1x |
| Dividend yield | 0.64% | 1.05% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Net margin34.98%vs -35.89%+197%
- Revenue CAGR 5y23.17%vs -8.23%+136%
- Market cap$946.37Bvs $5.74B+99%
- ROIC (TTM)32.06%vs 2.73%+91%
TFX leads on
- P/E (TTM)-vs 35.6x+116%
- Debt / Equity0.1xvs 1.4x+96%
- Dividend yield1.05%vs 0.64%+39%
- EV/EBIT21.9xvs 33.2x+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.